The service is based on RIKEN Genesis OncoPrime Basic test carried out at RIKEN Genesis Innovation Genome Center in Kawasaki and will first be limited to four national university hospitals (Tokyo University, Okayama University, Hokkaido University and Chiba University), to be eventually extended to 10 university hospitals. RIKEN Genesis is an affiliate company of Sysmex Corporation.
Mitsui Knowledge Industry news release, June 20, 2017
RIKEN Genesis and Mitsui Knowledgy Industry will offer sequencing service for cancer personalized treatment from July 2017